Literature DB >> 25399230

Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer.

Ami Vyas1, Suresh Madhavan, Usha Sambamoorthi.   

Abstract

Previous studies on the association between mammography screening and stage at breast cancer (BC) diagnosis have limitations because they did not analyze persistence with mammography screening and did not distinguish screening from diagnostic mammograms. The objective of this study is to determine the association between persistence with mammography screening and stage at BC diagnosis among elderly women. A retrospective observational study of 39,006 women age ≥70 diagnosed with incident BC from 2005 to 2009 from the Surveillance, Epidemiology, and End Results (SEER)-Medicare dataset was conducted. A validated algorithm with high sensitivity and specificity was used to distinguish between screening and diagnostic mammograms. Persistence with mammography screening was measured as having at least three screening mammograms in five years before BC diagnosis. Multinomial logistic regressions were performed to analyze the association between persistence with mammography screening and stage at diagnosis, in a multivariate framework. Overall, 46% of elderly women were persistent with mammography screening, 26% were not persistent, and 28% did not have any screening mammogram in five years before BC diagnosis. As compared to women who were not persistent with mammography screening, women who were persistent with mammography screening were significantly more likely to be diagnosed at earlier stages of BC. The adjusted odds ratios were 3.28, 2.37, and 1.60 for in situ, local, and regional stages, respectively. A lower proportion of elderly women was persistent with mammography and it was highly associated with earlier stages of BC diagnosis. Interventions designed to promote persistent mammography screening among elderly women are warranted.

Entities:  

Mesh:

Year:  2014        PMID: 25399230      PMCID: PMC4450353          DOI: 10.1007/s10549-014-3204-3

Source DB:  PubMed          Journal:  Breast Cancer Res Treat        ISSN: 0167-6806            Impact factor:   4.872


  31 in total

1.  Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology.

Authors:  N Krieger
Journal:  Am J Public Health       Date:  1992-05       Impact factor: 9.308

Review 2.  Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening.

Authors:  Robert A Smith; Deana Manassaram-Baptiste; Durado Brooks; Vilma Cokkinides; Mary Doroshenk; Debbie Saslow; Richard C Wender; Otis W Brawley
Journal:  CA Cancer J Clin       Date:  2014-01-09       Impact factor: 508.702

3.  Trends in distant-stage breast, colorectal, and prostate cancer incidence rates from 1992 to 2004: potential influences of screening and hormonal factors.

Authors:  Jean A McDougall; Christopher I Li
Journal:  Horm Cancer       Date:  2010-02-06       Impact factor: 3.869

4.  Variation in staging and treatment of local and regional breast cancer in the elderly.

Authors:  B E Hillner; L Penberthy; C E Desch; M K McDonald; T J Smith; S M Retchin
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

5.  Revisiting the behavioral model and access to medical care: does it matter?

Authors:  R M Andersen
Journal:  J Health Soc Behav       Date:  1995-03

6.  Effectiveness of population-based service screening with mammography for women ages 40 to 49 years: evaluation of the Swedish Mammography Screening in Young Women (SCRY) cohort.

Authors:  Barbro Numan Hellquist; Stephen W Duffy; Shahin Abdsaleh; Lena Björneld; Pál Bordás; László Tabár; Bedrich Viták; Sophia Zackrisson; Lennarth Nyström; Håkan Jonsson
Journal:  Cancer       Date:  2010-09-29       Impact factor: 6.860

7.  Screening outcomes in older US women undergoing multiple mammograms in community practice: does interval, age, or comorbidity score affect tumor characteristics or false positive rates?

Authors:  Dejana Braithwaite; Weiwei Zhu; Rebecca A Hubbard; Ellen S O'Meara; Diana L Miglioretti; Berta Geller; Kim Dittus; Dan Moore; Karen J Wernli; Jeanne Mandelblatt; Karla Kerlikowske
Journal:  J Natl Cancer Inst       Date:  2013-02-05       Impact factor: 13.506

8.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement.

Authors: 
Journal:  Ann Intern Med       Date:  2009-11-17       Impact factor: 25.391

9.  Distinguishing screening from diagnostic mammograms using Medicare claims data.

Authors:  Joshua J Fenton; Weiwei Zhu; Steven Balch; Rebecca Smith-Bindman; Paul Fishman; Rebecca A Hubbard
Journal:  Med Care       Date:  2014-07       Impact factor: 2.983

10.  Physician visits, patient comorbidities, and mammography use among elderly colorectal cancer survivors.

Authors:  Xinhua Yu; A Marshall McBean; Beth A Virnig
Journal:  J Cancer Surviv       Date:  2007-11-21       Impact factor: 4.442

View more
  10 in total

1.  Geographic Disparity in the Use of Hypofractionated Radiation Therapy Among Elderly Women Undergoing Breast Conservation for Invasive Breast Cancer.

Authors:  Erin F Gillespie; Rayna K Matsuno; Beibei Xu; Daniel P Triplett; Lindsay Hwang; Isabel J Boero; John P Einck; Catheryn Yashar; James D Murphy
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-05-12       Impact factor: 7.038

Review 2.  Breast Cancer Screening in Older Women: The Importance of Shared Decision Making.

Authors:  Sarina Schrager; Viktoriya Ovsepyan; Elizabeth Burnside
Journal:  J Am Board Fam Med       Date:  2020 May-Jun       Impact factor: 2.657

3.  Beyond the mammography debate: a moderate perspective.

Authors:  C Kaniklidis
Journal:  Curr Oncol       Date:  2015-06       Impact factor: 3.677

4.  A comparison of the stages at which cancer is diagnosed in physicians and in the general population in Taiwan.

Authors:  Yueh-Han Hsu; Pei-Tseng Kung; Yueh-Hsin Wang; Yao-Mao Chang; Wen-Chen Tsai
Journal:  CMAJ       Date:  2015-07-20       Impact factor: 8.262

5.  Naïve Bayesian network-based contribution analysis of tumor biology and healthcare factors to racial disparity in breast cancer stage-at-diagnosis.

Authors:  Yi Luo; Henry Carretta; Inkoo Lee; Gabrielle LeBlanc; Debajyoti Sinha; George Rust
Journal:  Health Inf Sci Syst       Date:  2021-09-24

Review 6.  The Landmark Series-Addressing Disparities in Breast Cancer Screening: New Recommendations for Black Women.

Authors:  Oluwadamilola M Fayanju; Christine E Edmonds; Sylvia A Reyes; Cletus Arciero; Vivian J Bea; Angelena Crown; Kathie-Ann Joseph
Journal:  Ann Surg Oncol       Date:  2022-10-03       Impact factor: 4.339

7.  Low Rates of Medical Oncology Consultation for Older Women (≥ 70 Years) with Newly Diagnosed, Non-Metastatic Breast Cancer: A Population-Based Study.

Authors:  Gary Ko; Julie Hallet; Katarzyna J Jerzak; Wing Chan; Natalie Coburn; Victoria Barabash; Frances C Wright; Nicole J Look Hong
Journal:  Ann Surg Oncol       Date:  2022-10-18       Impact factor: 4.339

Review 8.  Mobile Mammography Services and Underserved Women.

Authors:  Usha Trivedi; Toma S Omofoye; Cindy Marquez; Callie R Sullivan; Diane M Benson; Gary J Whitman
Journal:  Diagnostics (Basel)       Date:  2022-04-05

Review 9.  Updated Overview of the SEER-Medicare Data: Enhanced Content and Applications.

Authors:  Lindsey Enewold; Helen Parsons; Lirong Zhao; David Bott; Donna R Rivera; Michael J Barrett; Beth A Virnig; Joan L Warren
Journal:  J Natl Cancer Inst Monogr       Date:  2020-05-01

Review 10.  Older breast cancer undertreatment: unconscious bias to undertreat-potential role for the international geriatric radiotherapy group?

Authors:  Nam P Nguyen; Ulf Karlsson; Eromosele Oboite; Julio Alvarenga; Juan Godinez; Alice Zamagni; Micaela Motta; Satya Bose; Vincent Vinh-Hung
Journal:  Transl Cancer Res       Date:  2020-01       Impact factor: 1.241

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.